New mitochondrial transplantation via red blood cell encapsulation shows 50% efficiency boost and improved motor function in Parkinson’s models, with FDA fast-tracking clinical trials. Recent st...
Emerging research shows that enhancing mRNA surveillance mechanisms like nonsense-mediated decay can reduce neurodegeneration, with innovative therapies targeting tau aggregation offering new hope. Re...
Recent studies reveal aging microglia can promote amyloid-β aggregation, shifting Alzheimer’s pathology understanding and highlighting new therapeutic strategies targeting immune-brain interact...
7-ketocholesterol (7KC), an oxidized cholesterol, is linked to cardiovascular and neurodegenerative diseases, with recent AI diagnostics and clinical trials advancing preventive healthcare for aging p...
Recent studies reveal elevated IL-6 levels strongly correlate with Alzheimer’s and mild cognitive impairment, highlighting inflammaging’s role and potential for lifestyle and drug interven...
Research shows muscularis macrophages in the gut trigger α-synuclein misfolding in Parkinson’s disease, spreading to the brain via immune pathways, with potential for early intervention through...
Recent studies reveal that cystathionine γ-lyase (CSE) deficiency accelerates brain aging via reduced hydrogen sulfide, offering new therapeutic avenues for neurodegenerative diseases. Groundbreaking...
Recent research shows compounds like P7C3-A20 restore NAD+ levels, reversing Alzheimer’s pathology in mice, with early clinical trials indicating safety and potential efficacy in humans. Breakth...
Recent studies reveal GSH-DNA adducts as critical mitochondrial DNA damage markers linked to aging and neurodegeneration, with new insights into repair mechanisms and therapeutic potentials. A breakth...
Recent research identifies OTULIN as a key regulator of tau in neurons, offering a novel approach for Alzheimer’s disease by modulating production instead of clearance, with potential for person...
